Publications

Noninvasive identification of lineage-specific circular RNA for ER-positive breast cancer.
Brown, J, Shah, P, Vo, J, Xiao, L, Niknafs, Y, Cao, X, Chinnaiyan, A, Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.3543
PMID:
Investigating potential disparities in clinical trial eligibility, offers and enrollment at an NCI-designated comprehensive cancer center.
Patel, MA, Brinley, FJ, Shah, JL, Abrahamse, P, Veenstra, CM, Schott, AF, Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.e19076
PMID:
CheckMate 067: Long-term outcomes in patients with mucosal melanoma.
Shoushtari, AN, Wagstaff, J, Ascierto, PA, Butler, MO, Lao, CD, Marquez-Rodas, I, Chiarion-Sileni, V, Dummer, R, Ferrucci, PF, Lorigan, P, Smylie, M, van Dijck, W, Rizzo, JI, Hodi, FS, Larkin, JMG, Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.10019
PMID:
Clinical experience of ONC201 in patients with recurrent H3 K27M-mutant spinal cord glioma.
Kurz, SC, Tarapore, R, Odia, Y, Butowski, NA, Koschmann, CJ, Aguilera, D, MacDonald, TJ, Lu, G, Allen, JE, Oster, W, Mehta, MP, Chi, AS, Wen, PY, Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.2563
PMID:
ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG.
Gardner, SL, Koschmann, CJ, Tarapore, R, Allen, JC, Zaky, WT, Odia, Y, Hall, M, Daghistani, D, Khatib, Z, Aguilera, D, MacDonald, TJ, Fouladi, M, McGovern, SL, Kline, C, Vitanza, NA, Lu, G, Oster, W, Allen, JE, Khatua, S, Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.3619
PMID:
Association of LRP1B pathogenic genomic alterations with favorable outcomes with immune checkpoint inhibitors across multiple tumor types.
Brown, LC, Sedhom, R, Schwartz, EB, Zhu, J, Kao, C, Tucker, MD, Labriola, M, Gupta, RT, Marin, D, Wu, Y, Zhang, T, Harrison, MR, George, DJ, Alva, AS, Antonarakis, ES, Armstrong, AJ, Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.3007
PMID:
Association of molecular subtypes with pathologic response in a phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy (NAC) for localized, muscle-invasive bladder cancer (SWOG S1314; NCT02177695).
Lerner, SP, McConkey, DJ, Tangen, C, Meeks, JJ, Flaig, TW, Hua, X, Daneshmand, S, Alva, AS, Lucia, MS, Theodorescu, D, Goldkorn, A, Milowsky, MI, Choi, W, Bangs, RC, Gustafson, D, Thompson, IM, Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.5028
PMID:
Outcomes of patients (pts) with metastatic urothelial carcinoma (mUC) following discontinuation of enfortumab-vedotin (EV): Emergence of a new unmet need.
Curran, C, Pond, GR, Kazakova, V, Grivas, P, Diamantopoulos, LN, Alva, AS, Su, C, Jain, RK, Tandon, A, Zhang, J, Necchi, A, Marandino, L, Merchan, JR, Plastini, TM, Sonpavde, G, Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.5048
PMID:
HPV ctDNA analysis in unresectable recurrent/metastatic oropharyngeal cancer.
Haring, CT, Brummel, C, Jewell, B, Heft Neal, M, Bellile, E, Spector, ME, Mierzwa, M, Worden, FP, Tewari, M, Brenner, C, Swiecicki, P, Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.6554
PMID:
Discovery of m-808 as a highly potent, covalent, small-molecule inhibitor of the menin-mll interaction with strong in vivo antitumor activity
Xu, S, Aguilar, A, Huang, L, Xu, T, Zheng, K, McEachern, D, Przybranowski, S, Foster, C, Zawacki, K, Liu, Z, Chinnaswamy, K, Stuckey, J, Wang, S, J Med Chem, 2020 May; DOI:10.1021/acs.jmedchem.0c00547
PMID: 32338903
Prospective monitoring of imaging guideline adherence by physicians in a surgical collaborative: Comparison of statistical process control methods for detecting outlying performance
Inadomi, M, Singh, K, Qi, J, Dunn, R, Linsell, S, Denton, B, Hurley, P, Kleer, E, Montie, J, Ghani, KR, Michigan Urological Surgery Improvement Collaborative (MUSIC), Array, BMC Med Inform Decis Mak, 2020 May; DOI:10.1186/s12911-020-1126-z
PMID: 32404086
Therapy for stage IV non–small-cell lung cancer without driver alterations: ASCO and OH (CCO) joint guideline update
Hanna, NH, Schneider, BJ, Temin, S, Baker, S, Brahmer, J, Ellis, PM, Gaspar, LE, Haddad, RY, Hesketh, PJ, Jain, D, Jaiyesimi, I, Johnson, DH, Leighl, NB, Phillips, T, Riely, GJ, Robinson, AG, Rosell, R, Schiller, JH, Singh, N, Spigel, DR, Stabler, JO, Tashbar, J, Masters, G, J Clin Oncol, 2020 May; DOI:10.1200/JCO.19.03022
PMID: 31990617
SAT-172 FDG PET/CT in Benign vs. Malignant Adrenocortical Tumors
He, X, Caoili, EM, Avram, AM, Miller, BS, Else, T, Journal of the Endocrine Society, 2020 May; DOI:10.1210/jendso/bvaa046.1416
PMID:
MON-501 Physician-Reported Misuse of Thyroid Ultrasound
Chen, DW, Reyes-Gastelum, D, Radhakrishnan, A, Hamilton, AS, Ward, KC, Haymart, MR, Journal of the Endocrine Society, 2020 May; DOI:10.1210/jendso/bvaa046.460
PMID:
Practice Patterns for the Treatment of Uveal Melanoma with Iodine-125 Plaque Brachytherapy: Ocular Oncology Study Consortium Report 5
Binder, C, Mruthyunjaya, P, Schefler, AC, Seider, MI, Crilly, R, Hung, A, Meltsner, S, Mowery, Y, Kirsch, DG, Teh, BS, Jennelle, RLS, Studenski, MT, Liu, W, Lee, C, Hayman, JA, Kastner, B, Hadsell, M, Skalet, AH, Ocul Oncol Pathol, 2020 May; DOI:10.1159/000504312
PMID: 32509767
Efficacy and Safety of Limited-Margin Conformal Radiation Therapy for Pediatric Rhabdomyosarcoma: Long-Term Results of a Phase 2 Study
Tinkle, CL, Pappo, A, Wu, J, Mao, S, Hua, C-H, Shulkin, BL, McCarville, MB, Kaste, SC, Davidoff, AM, Bahrami, A, Green, DM, Ness, KK, Merchant, TE, Spunt, SL, Krasin, MJ, Int J Radiat Oncol Biol Phys, 2020 May; DOI:10.1016/j.ijrobp.2020.01.011
PMID: 31987969
The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activity
Huang, W, Ray, P, Ji, W, Wang, Z, Nancarrow, D, Chen, G, Galbán, S, Lawrence, TS, Beer, DG, Rehemtulla, A, Ramnath, N, Ray, D, J Biol Chem, 2020 May; DOI:10.1074/jbc.RA119.011869
PMID: 32165494
Abstract A20: An essential role for Argonaute 2 in mouse models of KRAS driven cancers
Shankar, S, Tien, JC-Y, Siebenaler, RF, Dommeti, VL, Zelenka-Wang, S, Waninger, J, Wang, X-M, Juckette, KM, Xu, A, Chugh, S, Mody, M, Eyunni, S, Goodrum, A, Tsaloff, G, Zhang, Y, Apel, IJ, Wang, L, Siddiqui, J, Smith, RD, Carlson, HA, Tesmer, J, Cao, X, Shi, J, Kumar-Sinha, C, Chinnaiyan, AM, Molecular Cancer Research, 2020 May; DOI:10.1158/1557-3125.ras18-a20
PMID:
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
Landi, MT, Bishop, DT, MacGregor, S, Machiela, MJ, Stratigos, AJ, Ghiorzo, P, Brossard, M, Calista, D, Choi, J, Fargnoli, MC, Zhang, T, Rodolfo, M, Trower, AJ, Menin, C, Martinez, J, Hadjisavvas, A, Song, L, Stefanaki, I, Scolyer, R, Yang, R, Goldstein, AM, Potrony, M, Kypreou, KP, Pastorino, L, Queirolo, P, Pellegrini, C, Cattaneo, L, Zawistowski, M, Gimenez-Xavier, P, Rodriguez, A, Elefanti, L, Manoukian, S, Rivoltini, L, Smith, BH, Loizidou, MA, Del Regno, L, Massi, D, Mandala, M, Khosrotehrani, K, Akslen, LA, Amos, CI, Andresen, PA, Avril, M-F, Azizi, E, Soyer, HP, Bataille, V, Dalmasso, B, Bowdler, LM, Burdon, KP, Chen, WV, Codd, V, Craig, JE, Dębniak, T, Falchi, M, Fang, S, Friedman, E, Simi, S, Galan, P, Garcia-Casado, Z, Gillanders, EM, Gordon, S, Green, A, Gruis, NA, Hansson, J, Harland, M, Harris, J, Helsing, P, Henders, A, Hočevar, M, Höiom, V, Hunter, D, Ingvar, C, Kumar, R, Lang, J, Lathrop, GM, Lee, JE, Li, X, Lubiński, J, Mackie, RM, Malt, M, Malvehy, J, McAloney, K, Mohamdi, H, Molven, A, Moses, EK, Neale, RE, Novaković, S, Nyholt, DR, Olsson, H, Orr, N, Fritsche, LG, Puig-Butille, JA, Qureshi, AA, Radford-Smith, GL, Randerson-Moor, J, Requena, C, Rowe, C, Samani, NJ, Sanna, M, Schadendorf, D, Schulze, H-J, Simms, LA, Smithers, M, Song, F, Swerdlow, AJ, van der Stoep, N, Kukutsch, NA, Visconti, A, Wallace, L, Ward, SV, Wheeler, L, Sturm, RA, Hutchinson, A, Jones, K, Malasky, M, Vogt, A, Zhou, W, Pooley, KA, Elder, DE, Han, J, Hicks, B, Hayward, NK, Kanetsky, PA, Brummett, C, Montgomery, GW, Olsen, CM, Hayward, C, Dunning, AM, Martin, NG, Evangelou, E, Mann, GJ, Long, G, Pharoah, PDP, Easton, DF, Barrett, JH, Cust, AE, Abecasis, G, Duffy, DL, Whiteman, DC, Gogas, H, De Nicolo, A, Tucker, MA, Newton-Bishop, JA, GenoMEL Consortium, Array, Q-MEGA and QTWIN Investigators, Array, ATHENS Melanoma Study Group, Array, 23andMe, Array, SDH Study Group, Array, IBD Investigators, Array, Essen-Heidelberg Investigators, Array, AMFS Investigators, Array, MelaNostrum Consortium, Array, Peris, K, Chanock, SJ, Demenais, F, Brown, KM, Puig, S, Nagore, E, Shi, J, Iles, MM, Law, MH, Nat Genet, 2020 May; DOI:10.1038/s41588-020-0611-8
PMID: 32341527
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy
Yeh, H-C, Margulis, V, Singla, N, Hernandez, E, Panwar, V, Woldu, SL, Karam, JA, Wood, CG, Weizer, AZ, Raman, JD, Remzi, M, Rioux-Leclercq, N, Haitel, A, Roscigno, M, Bolenz, C, Bensalah, K, Li, C-C, Ke, H-L, Li, W-M, Lee, H-Y, Rapoport, LM, Lotan, Y, Kapur, P, Shariat, SF, Hsieh, J-T, Wu, W-J, Urol Oncol, 2020 May; DOI:10.1016/j.urolonc.2019.11.010
PMID: 31862213
CX3CR1<sup>-</sup>CD8<sup>+</sup> T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment
Yamauchi, T, Hoki, T, Oba, T, Saito, H, Attwood, K, Sabel, MS, Chang, AE, Odunsi, K, Ito, F, JCI Insight, 2020 Apr; DOI:10.1172/jci.insight.133920
PMID: 32255766
CDK12-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade.
Schweizer, MT, Ha, G, Gulati, R, Brown, LC, McKay, RR, Dorff, T, Hoge, ACH, Reichel, J, Vats, P, Kilari, D, Patel, V, Oh, WK, Chinnaiyan, A, Pritchard, CC, Armstrong, AJ, Montgomery, RB, Alva, A, JCO Precis Oncol., 2020 Apr;
PMID:
Phase Ib/II clinical trial of pembrolizumab with bevacizumab for metastatic renal cell carcinoma: BTCRC-GU14-003
Dudek, AZ, Liu, LC, Gupta, S, Logan, TF, Singer, EA, Joshi, M, Zakharia, YN, Lang, JM, Schwarz, JK, Al-Janadi, A, Alva, AS, J Clin Oncol, 2020 Apr; DOI:10.1200/JCO.19.02394
PMID: 32097091
A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignancies
Taylor, MH, Alva, AS, Larson, T, Szpakowski, S, Purkaystha, D, Amin, A, Karpiak, L, Piha-Paul, SA, Oncotarget, 2020 Apr; DOI:10.18632/oncotarget.27530
PMID: 32292573
Visual field fluctuations correlating with the menstrual cycle in a patient with optic pathway glioma
Jacobson, A, Leonard, M, Robertson, P, Bohnsack, BL, BMJ Case Rep, 2020 Apr; DOI:10.1136/bcr-2019-234014
PMID: 32269049